Role of annexin A5 in cisplatin-induced toxicity in renal cells molecular mechanism of apoptosis

Journal of Biological Chemistry

Volumn 289, Issue 4, 2014, Pages 2469-2481

  Jeong, Jin Joo ^a   Park, Nahee ^a   Kwon, Yeo Jung ^a   Ye, Dong Jin ^a   Moon, Aree ^b   Chun, Young Jin ^a  

^a Chung Ang University   (South Korea)

^b Duksung Women's University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANNEXIN A5; APOPTOTIC PATHWAYS; CIS-PLATIN; MITOCHONDRIAL TRANSLOCATION; MOLECULAR MECHANISM; RENAL CELL; RENAL EPITHELIAL CELLS;

CELL DEATH; PLATINUM COMPOUNDS; TOXICITY;

ANTIBIOTICS;

APOPTOSIS INDUCING FACTOR; BACITRACIN; CADMIUM CHLORIDE; CISPLATIN; HOMODIMER; LIPOCORTIN 5; OLIGOMER; SMALL INTERFERING RNA; VOLTAGE DEPENDENT ANION CHANNEL;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOSOL; CYTOTOXICITY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; KIDNEY EPITHELIUM; MITOCHONDRIAL MEMBRANE POTENTIAL; NEPHROTOXICITY; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; TOXICITY TESTING; UPREGULATION; WESTERN BLOTTING;

ANNEXIN; ANNEXIN A5; CISPLATIN; KIDNEY; MITOCHONDRIAL APOPTOSIS; NEPHROTOXICITY; PROTEIN TRANSLOCATION; RENAL EPITHELIAL CELL; SIRNA; VDAC;

ANIMALS; ANNEXIN A5; ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; APOPTOSIS; APOPTOSIS INDUCING FACTOR; BACITRACIN; CADMIUM CHLORIDE; CELL LINE; CISPLATIN; CYTOSOL; EPITHELIAL CELLS; GENE KNOCKDOWN TECHNIQUES; HUMANS; KIDNEY TUBULES, PROXIMAL; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; PROTEIN MULTIMERIZATION; PROTEIN TRANSPORT; RATS; VOLTAGE-DEPENDENT ANION CHANNELS;

EID: 84893104059     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.450163     Document Type: Article

References (36)

1. Desoize, B., and Madoulet, C. (2002) Particular aspects of platinum compounds used at present in cancer treatment. Crit. Rev. Oncol. Hematol. 42, 317-325
2. Park, M. S., De Leon, M., and Devarajan, P. (2002) Cisplatin induces apoptosis in LLC-PK1 cells via activation of mitochondrial pathways. J. Am. Soc. Nephrol. 13, 858-865
3. Hanigan, M. H., and Devarajan, P. (2003) Cisplatin nephrotoxicity: molecular mechanisms. Cancer Ther. 1, 47-61
4. Kim, S. Y., and Moon, A. (2012) Drug-induced nephrotoxicity and its biomarkers. Biomol. Ther. 20, 268-272
5. Fella, K., Glückmann, M., Hellmann, J., Karas, M., Kramer, P. J., and Kröger, M. (2005) Use of two-dimensional gel electrophoresis in predictive toxicology: identification of potential early protein biomarkers in chemically induced hepatocarcinogenesis. Proteomics 5, 1914-1927
6. Wang, E. J., Snyder, R. D., Fielden, M. R., Smith, R. J., and Gu, Y. Z. (2008) Validation of putative genomic biomarkers of nephrotoxicity in rats. Toxicology 246, 91-100
7. Simsek, B., Buyukcelik, M., Soran, M., Bayazit, A. K., Noyan, A., Seydaoglu, G., and Anarat, A. (2008) Urinary annexin V in children with nephrotic syndrome: a new prognostic marker? Pediatr. Nephrol. 23, 79-82
8. Markoff, A., and Gerke, V. (2005) Expression and functions of annexins in the kidney. Am. J. Physiol. Renal Physiol. 289, F949-F956
9. Hofstra, L., and Heymans, S. (2007) Annexin A5 and the failing heart; lost or found in translation? Eur. Heart. J. 28, 2695-2696
10. Matsuda, R., Kaneko, N., Horikawa, Y., Chiwaki, F., Shinozaki, M., Abe, S., Yumura, W., Nihei, H., and Ieiri, T. (2000) Measurement of urinary annexin V by ELISA and its significance as a new urinary-marker of kidney disease. Clin. Chim. Acta 298, 29-43
11. Shoshan-Barmatz, V., Keinan, N., and Zaid, H. (2008) Uncovering the role of VDAC in the regulation of cell life and death. J. Bioenerg. Biomembr. 40, 183-191
12. Shoshan-Barmatz, V., De Pinto, V., Zweckstetter, M., Raviv, Z., Keinan N., and Arbel, N. (2010) VDAC, a multi-functional mitochondrial protein regulating cell life and death. Mol. Aspects Med. 31, 227-285
13. Zalk, R., Israelson, A., Garty, E. S., Azoulay-Zohar, H., and Shoshan-Barmatz, V. (2005) Oligomeric states of the voltage-dependent anion channel and cytochrome c release from mitochondria. Biochem. J. 386, 73-83
14. Zheng, Y., Shi, Y., Tian, C., Jiang, C., Jin, H., Chen, J., Almasan, A., Tang, H., and Chen, Q. (2004) Essential role of the voltage-dependent anion channel (VDAC) in mitochondrial permeability transition pore opening and cytochrome c release induced by arsenic trioxide. Oncogene 23, 1239-1247
15. Shoshan-Barmatz, V., Keinan, N., Abu-Hamad, S., Tyomkin, D., and Aram, L. (2010) Apoptosis is regulated by the VDAC1 N-terminal region and by VDAC oligomerization: release of cytochrome c, AIF and Smac/ Diablo. Biochim. Biophys. Acta 1797, 1281-1291
16. Keinan, N., Tyomkin, D., and Shoshan-Barmatz, V. (2010) Oligomerization of the mitochondrial protein voltage-dependent anion channel is coupled to the induction of apoptosis. Mol. Cell. Biol. 30, 5698-5709
17. Tajeddine, N., Galluzzi, L., Kepp, O., Hangen, E., Morselli, E., Senovilla, L., Araujo, N., Pinna, G., Larochette, N., Zamzami, N., Modjtahedi, N., Harel-Bellan, A., and Kroemer, G. (2008) Hierarchical involvement of Bak, VDAC1 and Bax in cisplatin-induced cell death. Oncogene 27, 4221-4232
18. Schmittgen, T. D., and Livak, K. J. (2008) Analyzing real-time PCR data by the comparative CT method. Nat. Protoc. 3, 1101-1108
19. Candé, C., Cecconi, F., Dessen, P., and Kroemer, G. (2002) Apoptosisinducing factor (AIF): key to the conserved caspase-independent pathways of cell death? J. Cell Sci. 115, 4727-4734
20. Schwacha, M. G., Chaudry, I. H., and Alexander, M. (2003) Regulation of macrophage IL-10 production postinjury via β2 integrin signaling and the p38 MAP kinase pathway. Shock 20, 529-535
21. Floryk, D., and Houstěk, J. (1999) Tetramethylrhodamine methyl ester (TMRM) is suitable for cytofluorometric measurements of mitochondrial membrane potential in cells treated with digitonin. Biosci. Rep. 19, 27-34
22. Wong, A., and Cortopassi, G. A. (2002) High-throughput measurement of mitochondrial membrane potential in a neural cell line using a fluorescence plate reader. Biochem. Biophys. Res. Commun. 298, 750-754
23. Toescu, E. C., and Verkhratsky, A. (2000) Assessment of mitochondrial polarization status in living cells based on analysis of the spatial heterogeneity of rhodamine 123 fluorescence staining. Pflugers Arch. 440, 941-947
24. Lee, W. K., Bork, U., and Thévenod, F. (2004) Mitochondria as a target of cadmium nephrotoxicity: induction of swelling and cytochrome c release. Toxicol. Mech. Methods 14, 67-71
25. Ravassa, S., González, A., López, B., Beaumont, J., Querejeta, R., Larman, M., and Díez, J. (2007) Upregulation of myocardial annexin A5 in hypertensive heart disease: association with systolic dysfunction. Eur. Heart J. 28, 2785-2791
26. Bogdanova, N., Horst, J., Chlystun, M., Croucher, P. J., Nebel, A., Bohring, A., Todorova, A., Schreiber, S., Gerke, V., Krawczak, M., and Markoff, A. (2007) A common haplotype of the annexin A5 (ANXA5) gene promoter is associated with recurrent pregnancy loss. Hum. Mol. Genet. 16, 573-578
27. Giedroc, D. P., Chen, X., and Apuy, J. L. (2001) Metal response element (MRE)-binding transcription factor-1 (MTF-1): structure, function, and regulation. Antioxid. Redox Signal. 3, 577-596
28. Ravassa, S., García-Bolao, I., Zudaire, A., Macías, A., Gavira, J. J., Beaumont, J., Arias, T., Huerta, A., and Díez, J. (2010) Cardiac resynchronization therapy-induced left ventricular reverse remodelling is associated with reduced plasma annexin A5. Cardiovasc. Res. 88, 304-313
29. Ea, H. K., Monceau, V., Camors, E., Cohen-Solal, M., Charlemagne, D., and Lioté, F. (2008) Annexin 5 overexpression increased articular chondrocyte apoptosis induced by basic calcium phosphate crystals. Ann. Rheum. Dis. 67, 1617-1625
30. Chirino, Y. I., and Pedraza-Chaverri, J. (2009) Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity. Exp. Toxicol. Pathol. 61, 223-242
31. Scharstuhl, A., Mutsaers, H. A., Pennings, S. W., Russel, F. G., and Wagener, F. A. (2009) Involvement of VDAC, Bax and ceramides in the efflux of AIF from mitochondria during curcumin-induced apoptosis. PLoS ONE 4, e6688
32. van Engeland, M., Nieland, L. J., Ramaekers, F. C., Schutte, B., and Reutelingsperger, C. P. (1998) Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 31, 1-9
33. Rothhut, B., Dubois, T., Feliers, D., Russo-Marie, F., and Oudinet, J. P. (1995) Inhibitory effect of annexin V on protein kinase C activity in mesangial cell lysates. Eur. J. Biochem. 232, 865-872
34. Kheifets, V., Bright, R., Inagaki, K., Schechtman, D., and Mochly-Rosen, D. (2006) Protein kinase Cδ (PKCδ)-annexin V interaction: a required step in PKCδ translocation and function. J. Biol. Chem. 281, 23218-23226
35. Majumder, P. K., Pandey, P., Sun, X., Cheng, K., Datta, R., Saxena, S., Kharbanda, S., and Kufe, D. (2000) Mitochondrial translocation of protein kinase Cδ in phorbol ester-induced cytochrome c release and apoptosis. J. Biol. Chem. 275, 21793-21796
36. Pabla, N., Dong, G., Jiang, M., Huang, S., Kumar, M. V., Messing, R. O., and Dong, Z. (2011) Inhibition of PKCδ reduces cisplatin-induced nephrotoxicity without blocking chemotherapeutic efficacy in mouse models of cancer. J. Clin. Invest. 121, 2709-2722